JAC Advance Access published online on August 13, 2003
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg384
© 2003 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original article
1 Servicio de Microbiología,
Hospital Universitario de Valme, Sevilla;
* Corresponding author. E-mail: canton_emi{at}gva.es.
Received 31 March 2003
; revised 20 June 2003
; accepted 21 June 2003
Objective: The evaluation of the Sensititre
YeastOne and Etest methods for determining susceptibility to amphotericin
B and itraconazole by comparing the MICs obtained by these methods
at different times of reading with those of the M38-A broth microdilution
method. Methods: Sixty-three clinical isolates of Aspergillus spp. (23 Aspergillus flavus,
24 Aspergillus fumigatus, nine Aspergillus
niger, three Aspergillus glaucus, two Aspergillus
terreus and two Aspergillus flavipes) were
assayed. Two itraconazole-resistant strains (NCPF7100 and 7099)
were also included. Results: Itraconazole MICs for the two resistant
strains were >4 mg/L by the three methods. The overall agreement
(±2 log2) between M38-A (48
h) and colorimetric (48 h) method was 93.4% for amphotericin
B and 90.2% for itraconazole. By the Etest, the best agreement
with M38-A was obtained when readings were made at 24 h: 88.5% for
amphotericin B and 67.2% for itraconazole. Etest MICs were
higher for all species except A. niger. Conclusions: The colorimetric method appears
to be a suitable alternative procedure for antifungal susceptibility
testing of Aspergillus spp. and is able to detect
resistance to itraconazole. The range of MICs for amphotericin B
by Etest is wider and for some strains is >16 mg/L, suggesting
that this method could be useful for detecting resistant strains
as occur in yeasts.
Keywords: Aspergillus spp., susceptibility
testing, MIC, Sensititre YeastOne
Comparison of the Sensititre YeastOne colorimetric
antifungal
panel and Etest with the NCCLS M38-A method to determine the activity
of amphotericin B and itraconazole against clinical isolates
of Aspergillus spp
2 Servicio de Microbiología, Hospital Universitario
La Fe, Valencia;
3 Unidad
de Bacteriología Experimental, Centro de Investigación,
Hospital Universitario La Fe, Avenida Campanar 21, 46009 Valencia,
Spain
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Alvarado-Ramirez and J. M. Torres-Rodriguez In Vitro Susceptibility of Sporothrix schenckii to Six Antifungal Agents Determined Using Three Different Methods Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2420 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Espinel-Ingroff Comparison of Three Commercial Assays and a Modified Disk Diffusion Assay with Two Broth Microdilution Reference Assays for Testing Zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with Posaconazole and Amphotericin B J. Clin. Microbiol., October 1, 2006; 44(10): 3616 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. J. van de Sande, A. Luijendijk, A. O. A. Ahmed, I. A. J. M. Bakker-Woudenberg, and A. van Belkum Testing of the In Vitro Susceptibilities of Madurella mycetomatis to Six Antifungal Agents by Using the Sensititre System in Comparison with a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5- [(Phenylamino)Carbonyl]-2H-Tetrazolium Hydroxide (XTT) Assay and a Modified NCCLS Method Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1364 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canton, J. Peman, M. Gobernado, E. Alvarez, F. Baquero, R. Cisterna, J. Gil, E. Martin-Mazuelos, C. Rubio, A. Sanchez-Sousa, et al. Sensititre YeastOne Caspofungin Susceptibility Testing of Candida Clinical Isolates: Correlation with Results of NCCLS M27-A2 Multicenter Study Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1604 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Castro, M. C. Serrano, B. Flores, A. Espinel-Ingroff, and E. Martin-Mazuelos Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with a Modified NCCLS M38-A Method To Determine the Activity of Voriconazole against Clinical Isolates of Aspergillus spp. J. Clin. Microbiol., September 1, 2004; 42(9): 4358 - 4360. [Abstract] [Full Text] [PDF] |
||||

